WOKPROL AM 5 MG/50 MG TABLET contains two meds, the two of which help to control hypertension and pulse. It is likewise utilized for heart-related chest torment, unusual heart rhythms and persistent (long haul) cardiovascular breakdown.
You can take WOKPROL AM 5 MG/50 MG TABLET whenever of day, regardless of food, however taking it simultaneously every day is ideal. Continue to take it however long prompted by your PCP. Regardless of whether you feel good, don’t stop this medication all alone in light of the fact that hypertension frequently has no side effects. Assuming you quit taking it, your condition might deteriorate. Keeping dynamic with customary Activity, lessening your weight and eating a sound eating routine will likewise assist with controlling your circulatory strain. Heed your PCP’s guidance while taking this medication.
Cefuroxime 250mg+ Clavulanic Acid – Blister Strip
Cefuroxime 250mg+ Clavulanic Acid – Blister Strip
Sub Category: Infectious Disease Drugs
Packaging Details: 6 tablets in 1 strip
Product Composition: Cefuroxime 250mg+ Clavulanic Acid
Product Uses: WOKPROL AM 5mg/50mg TABLET is utilized in the treatment of hypertension.
Category:
Blister Strip
Pregnancy Interaction: Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. WOKPROL AM 5mg/50mg TABLET is to be taken with food.
Prescription: Yes
Food Interaction: Headache, Ankle swelling, Flushing (sense of warmth in the face, ears, neck and trunk), Slow heart rate, Tiredness, Stomach pain, Nausea, Edema (swelling), Constipation, Palpitations, Cold extremities.
Breast Feeding Interaction: WOKPROL AM 5mg/50mg TABLET is a combination of two medicines: Amlodipine and metoprolol which lower blood pressure effectively. Amlodipine is a calcium channel blocker which works by relaxing blood vessels while metoprolol is a beta blocker that works specifically on the heart to slow down the heart rate. Together, they make the heart more efficient at pumping blood throughout the body.
